News


SRI biosciences wins $100 million for radiation research

 

One hundred million dollars over five years. That's how much the SRI International biosciences division is being awarded as part of a contract to research and develop products to address the effects of radiation exposure.

The multi-year contract was awarded by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health.

The principal investigator for the contract will be Polly Chang, senior director of molecular and genetic toxicology at SRI Biosciences. The award will support work related to developing medical "countermeasures" to address the effects of radiation and nuclear exposure.

SRI International is based in Menlo Park.

Kate Bradshaw

Comments

Sorry, but further commenting on this topic has been closed.

Orenchi Ramen expands to Redwood City
By Elena Kadvany | 0 comments | 4,432 views

Sharing A Column About a Brilliant Teacher Idea
By Steve Levy | 6 comments | 1,381 views

Family Matters: Caring for the Dying, and Their Loved Ones
By Aldis Petriceks | 3 comments | 902 views

A fast approaching birthday
By Cheryl Bac | 0 comments | 597 views

Henry and Fluffy, On Duty
By Stuart Soffer | 0 comments | 242 views